PFENYSEPharmaceutical PreparationsFiscal year ends December 31

PFIZER INC

Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Aug 4, 2026

$29.44−0.14 (-0.47%)

Close on Oct 19, 2026

Market cap: $167.78B
P/E (TTM): 38.7
Dividend yield: 5.84%

PFIZER INC income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31	FY 2008 2008-12-31	FY 2007 2007-12-31
Revenue	62,579	63,627	59,553	101,175	81,288	41,651	40,905	40,825	52,546	52,824	48,851	49,605	51,584	54,657	61,035	65,165	49,269	48,296	48,418
Cost of Revenue	16,067	17,851	24,954	34,344	30,821	8,484	8,054	8,987	11,228	12,322	9,648	9,577	9,586	9,821	12,500	14,788	8,459	8,112	11,239
Gross Profit	46,512	45,776	34,599	66,831	50,467	33,167	32,851	31,838	41,318	40,502	39,203	40,028	41,998	44,836	48,535	50,377	40,810	40,184	37,179
Research & Development	10,437	10,822	10,679	11,428	10,360	8,709	8,385	7,760	7,683	7,892	7,690	8,393	6,678	7,482	8,681	9,483	7,824	7,945	8,089
Selling, General & Admin	13,794	14,730	14,771	13,677	12,703	11,597	12,726	12,612	14,804	14,844	14,809	14,097	14,355	15,171	17,581	18,973	14,752	14,537	15,626
Advertising Expenses	2,700	3,300	3,700	2,800	2,000	1,800	2,300	2,700	3,100	3,200	3,100	3,100	3,000	2,800	3,600	3,800	2,900	2,600	–
Interest Expense	2,671	3,091	2,209	1,238	1,291	1,449	1,573	1,316	1,270	1,186	1,199	1,360	1,414	1,522	1,681	1,797	1,232	516	–
Interest & Investment Income	603	545	1,624	251	36	73	225	333	391	470	471	425	403	382	–	–	–	–	–
Income from Equity Investments	–	–	–	–	–	–	–	–	–	–	45	86	–	–	–	–	–	–	–
Other Non-Operating Income	-6,724	-4,388	-222	-1,062	4,878	-1,213	-3,497	-2,077	-1,416	-3,794	-2,860	-1,009	532	-4,022	-139	147	-62	-48	–
Merger & Restructuring Charges	1,092	1,987	1,968	882	741	535	227	796	30	1,055	811	170	1,038	1,428	2,118	–	–	–	–
Asset Impairment Charges	4,940	3,295	3,024	421	86	1,691	2,792	3,115	395	1,447	818	469	878	890	1,198	3,486	305	570	2,220
Gain (Loss) on Investments	-67	1,008	1,590	-1,273	1,344	540	454	586	224	18	–	–	–	–	–	–	–	–	–
Gain (Loss) on Sale of Assets	–	–	222	0	99	-237	32	71	-45	51	0	–	320	52	40	243	188	14	–
Legal Settlements	-1,057	-567	-474	-230	-182	-28	-292	-84	-240	-510	-975	0	1,342	0	0	–	–	–	–
Pretax Income	7,520	8,023	1,058	34,729	24,311	7,036	11,321	3,594	12,305	8,351	8,965	12,240	15,716	11,242	11,481	9,471	10,674	9,694	9,278
Income Tax Expense	-266	-28	-1,115	3,328	1,852	370	583	-266	-9,049	1,123	1,990	3,120	4,306	2,221	3,621	1,153	2,145	1,645	1,023
Income from Continuing Operations	7,787	8,051	2,172	31,401	22,459	6,666	10,708	3,825	21,306	7,198	6,949	9,087	11,380	8,993	7,820	8,287	8,521	8,026	8,255
Income from Discontinued Operations	25	11	-15	6.00	-434	2,529	5,318	7,328	2.00	17	11	48	10,662	5,577	2,189	-30	114	78	-69
Net Income incl. Noncontrolling Interests	7,812	8,062	2,158	31,407	22,025	9,195	16,056	11,188	21,355	7,246	6,986	9,168	22,072	14,598	10,049	8,288	8,643	8,127	8,186
Minority Interest in Earnings	41	31	39	35	45	36	29	36	47	31	26	32	69	28	40	31	8.00	23	42
Net Income	7,771	8,031	2,119	31,372	21,979	9,159	16,026	11,153	21,308	7,215	6,960	9,135	22,003	14,570	10,009	8,257	8,635	8,104	8,144
Preferred Dividends	–	–	–	–	0	0	1.00	1.00	1.00	1.00	1.00	1.00	2.00	2.00	2.00	2.00	2.00	–	–
Net Income to Common	7,771	8,031	2,119	31,372	21,979	9,159	16,025	11,152	21,307	7,214	6,959	9,134	22,001	14,568	10,007	8,255	8,633	8,101	–
EPS (Basic)(per share)	1.37	1.42	0.38	5.59	3.92	1.65	2.88	1.90	3.57	1.18	1.13	1.44	3.23	1.96	1.28	1.03	1.23	1.20	1.18
EPS (Diluted)(per share)	1.36	1.41	0.37	5.47	3.85	1.63	2.82	1.87	3.52	1.17	1.11	1.42	3.19	1.94	1.27	1.02	1.23	1.20	1.17
Shares Outstanding (Basic, Weighted)(shares)	5,683	5,664	5,643	5,608	5,601	5,555	5,569	5,872	5,970	6,089	6,176	6,346	6,813	7,442	7,817	8,036	7,007	6,727	6,917
Shares Outstanding (Diluted, Weighted)(shares)	5,713	5,700	5,709	5,733	5,708	5,632	5,675	5,977	6,058	6,159	6,257	6,424	6,895	7,508	7,870	8,074	7,045	6,750	6,939
Dividend per Share(per share)	1.72	1.69	1.65	1.61	1.57	1.53	1.46	1.38	1.30	1.22	1.12	1.04	0.96	0.88	0.80	0.72	–	–	–
Net Interest Income	–	–	–	–	–	–	–	–	–	–	–	–	-1,011	-1,140	-1,225	–	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 28, 2026

Profitability, TTM

Gross margin: 73.2%
Operating margin: –
Net margin: 6.8%
Return on equity, FY2025: 8.9%

Financial strength

Current ratio: 1.27
Debt to equity: 0.74
Debt to assets: 31.4%
Cash to current liabilities: 3.0%

Valuation

P/E ratio: 38.7
Price to sales: 2.63
Price to book: 1.97
Dividend yield: 5.84%